Filing Details

Accession Number:
0001179110-17-013103
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-04 16:30:24
Reporting Period:
2017-10-02
Accepted Time:
2017-10-04 16:30:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1650664 Editas Medicine Inc. EDIT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1592469 Katrine Bosley C/O Editas Medicine, Inc.
11 Hurley St.
Cambridge MA 02141
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-10-02 8,133 $24.77 1,399,630 No 4 S Direct
Common Stock Disposition 2017-10-02 200 $25.33 1,399,430 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2017.
  2. This transaction was executed in multiple trades at prices ranging from $24.2 to $25.17. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected
  3. This transaction was executed in multiple trades at prices ranging from $25.32 to $25.34. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected